Literature DB >> 33523367

CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors.

Giulia Benedetti1,2, Martina Mori3, Marta Maria Panzeri1, Maurizio Barbera1, Diego Palumbo1, Carla Sini3, Francesca Muffatti4, Valentina Andreasi4, Stephanie Steidler1, Claudio Doglioni5,6, Stefano Partelli4,6, Marco Manzoni7, Massimo Falconi4,6, Claudio Fiorino3,6, Francesco De Cobelli8,9,10.   

Abstract

PURPOSE: To assess the ability of radiomic features (RF) extracted from contrast-enhanced CT images (ceCT) and non-contrast-enhanced (non-ceCT) in discriminating histopathologic characteristics of pancreatic neuroendocrine tumors (panNET).
METHODS: panNET contours were delineated on pre-surgical ceCT and non-ceCT. First- second- and higher-order RF (adjusted to eliminate redundancy) were extracted and correlated with histological panNET grade (G1 vs G2/G3), metastasis, lymph node invasion, microscopic vascular infiltration. Mann-Whitney with Bonferroni corrected p values assessed differences. Discriminative power of significant RF was calculated for each of the end-points. The performance of conventional-imaged-based-parameters was also compared to RF.
RESULTS: Thirty-nine patients were included (mean age 55-years-old; 24 male). Mean diameters of the lesions were 24 × 27 mm. Sixty-nine RF were considered. Sphericity could discriminate high grade tumors (AUC = 0.79, p = 0.002). Tumor volume (AUC = 0.79, p = 0.003) and several non-ceCT and ceCT RF were able to identify microscopic vascular infiltration: voxel-alignment, neighborhood intensity-difference and intensity-size-zone families (AUC ≥ 0.75, p < 0.001); voxel-alignment, intensity-size-zone and co-occurrence families (AUC ≥ 0.78, p ≤ 0.002), respectively). Non-ceCT neighborhood-intensity-difference (AUC = 0.75, p = 0.009) and ceCT intensity-size-zone (AUC = 0.73, p = 0.014) identified lymph nodal invasion; several non-ceCT and ceCT voxel-alignment family features were discriminative for metastasis (p < 0.01, AUC = 0.80-0.85). Conventional CT 'necrosis' could discriminate for microscopic vascular invasion (AUC = 0.76, p = 0.004) and 'arterial vascular invasion' for microscopic metastasis (AUC = 0.86, p = 0.001). No conventional-imaged-based-parameter was significantly associated with grade and lymph node invasion.
CONCLUSIONS: Radiomic features can discriminate histopathology of panNET, suggesting a role of radiomics as a non-invasive tool for tumor characterization. TRIAL REGISTRATION NUMBER: NCT03967951, 30/05/2019.

Entities:  

Keywords:  Area under the curve (AUC); Computed tomography; Neuroendocrine tumors; Pancreatic neoplasms; Radiomic features

Mesh:

Year:  2021        PMID: 33523367     DOI: 10.1007/s11547-021-01333-z

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  15 in total

Review 1.  Recent updates on grading and classification of neuroendocrine tumors.

Authors:  Joo Young Kim; Seung-Mo Hong; Jae Y Ro
Journal:  Ann Diagn Pathol       Date:  2017-04-13       Impact factor: 2.090

Review 2.  State-of-the-art Imaging of Pancreatic Neuroendocrine Tumors.

Authors:  Eric P Tamm; Priya Bhosale; Jeffrey H Lee; Eric M Rohren
Journal:  Surg Oncol Clin N Am       Date:  2016-04       Impact factor: 3.495

Review 3.  Radiomics of pulmonary nodules and lung cancer.

Authors:  Ryan Wilson; Anand Devaraj
Journal:  Transl Lung Cancer Res       Date:  2017-02

4.  Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: Comparison with tumour regression grade at final histology.

Authors:  Francesco Giganti; Paolo Marra; Alessandro Ambrosi; Annalaura Salerno; Sofia Antunes; Damiano Chiari; Elena Orsenigo; Antonio Esposito; Elena Mazza; Luca Albarello; Roberto Nicoletti; Carlo Staudacher; Alessandro Del Maschio; Francesco De Cobelli
Journal:  Eur J Radiol       Date:  2017-03-01       Impact factor: 3.528

5.  Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas.

Authors:  Margarita Kirienko; Gaia Ninatti; Luca Cozzi; Emanuele Voulaz; Nicolò Gennaro; Isabella Barajon; Francesca Ricci; Carmelo Carlo-Stella; Paolo Zucali; Martina Sollini; Luca Balzarini; Arturo Chiti
Journal:  Radiol Med       Date:  2020-04-18       Impact factor: 3.469

6.  Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics?

Authors:  Vinciane Rebours; Jacqueline Cordova; Anne Couvelard; Monique Fabre; Laurent Palazzo; Marie Pierre Vullierme; Olivia Hentic; Alain Sauvanet; Alain Aubert; Pierre Bedossa; Philippe Ruszniewski
Journal:  Dig Liver Dis       Date:  2015-06-20       Impact factor: 4.088

7.  Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.

Authors:  Mostafa Nazari; Isaac Shiri; Ghasem Hajianfar; Niki Oveisi; Hamid Abdollahi; Mohammad Reza Deevband; Mehrdad Oveisi; Habib Zaidi
Journal:  Radiol Med       Date:  2020-03-19       Impact factor: 3.469

8.  Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis.

Authors:  Tae Won Choi; Jung Hoon Kim; Mi Hye Yu; Sang Joon Park; Joon Koo Han
Journal:  Acta Radiol       Date:  2017-08-02       Impact factor: 1.990

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

Review 10.  Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation.

Authors:  Ilenia Bartolini; Lapo Bencini; Matteo Risaliti; Maria Novella Ringressi; Luca Moraldi; Antonio Taddei
Journal:  Gastroenterol Res Pract       Date:  2018-07-22       Impact factor: 2.260

View more
  27 in total

1.  Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade.

Authors:  Giuditta Chiti; Giulia Grazzini; Federica Flammia; Benedetta Matteuzzi; Paolo Tortoli; Silvia Bettarini; Elisa Pasqualini; Vincenza Granata; Simone Busoni; Luca Messserini; Silvia Pradella; Daniela Massi; Vittorio Miele
Journal:  Radiol Med       Date:  2022-08-02       Impact factor: 6.313

Review 2.  Role of Texture Analysis in Oropharyngeal Carcinoma: A Systematic Review of the Literature.

Authors:  Eleonora Bicci; Cosimo Nardi; Leonardo Calamandrei; Michele Pietragalla; Edoardo Cavigli; Francesco Mungai; Luigi Bonasera; Vittorio Miele
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

3.  Radiomics and machine learning analysis based on magnetic resonance imaging in the assessment of liver mucinous colorectal metastases.

Authors:  Vincenza Granata; Roberta Fusco; Federica De Muzio; Carmen Cutolo; Sergio Venanzio Setola; Federica Dell'Aversana; Francesca Grassi; Andrea Belli; Lucrezia Silvestro; Alessandro Ottaiano; Guglielmo Nasti; Antonio Avallone; Federica Flammia; Vittorio Miele; Fabiana Tatangelo; Francesco Izzo; Antonella Petrillo
Journal:  Radiol Med       Date:  2022-06-02       Impact factor: 6.313

4.  Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Giovanna Vacca; Giuliana Giacobbe; Antonio Angrisani; Alfredo Clemente; Ginevra Danti; Pierpaolo Correale; Salvatore Francesco Carbone; Luigi Pirtoli; Lorenzo Bianchi; Angelo Vanzulli; Cesare Guida; Roberto Grassi; Salvatore Cappabianca
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

Review 5.  Radiomics in medical imaging: pitfalls and challenges in clinical management.

Authors:  Roberta Fusco; Vincenza Granata; Giulia Grazzini; Silvia Pradella; Alessandra Borgheresi; Alessandra Bruno; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Andrea Giovagnoni; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2022-03-28       Impact factor: 2.701

6.  Structured Reporting of Computed Tomography in the Staging of Neuroendocrine Neoplasms: A Delphi Consensus Proposal.

Authors:  Vincenza Granata; Francesca Coppola; Roberta Grassi; Roberta Fusco; Salvatore Tafuto; Francesco Izzo; Alfonso Reginelli; Nicola Maggialetti; Duccio Buccicardi; Barbara Frittoli; Marco Rengo; Chandra Bortolotto; Roberto Prost; Giorgia Viola Lacasella; Marco Montella; Eleonora Ciaghi; Francesco Bellifemine; Federica De Muzio; Ginevra Danti; Giulia Grazzini; Massimo De Filippo; Salvatore Cappabianca; Carmelo Barresi; Franco Iafrate; Luca Pio Stoppino; Andrea Laghi; Roberto Grassi; Luca Brunese; Emanuele Neri; Vittorio Miele; Lorenzo Faggioni
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-30       Impact factor: 5.555

Review 7.  Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential.

Authors:  Xingping Zhang; Yanchun Zhang; Guijuan Zhang; Xingting Qiu; Wenjun Tan; Xiaoxia Yin; Liefa Liao
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244

8.  An update on radiomics techniques in primary liver cancers.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venazio Setola; Igino Simonetti; Diletta Cozzi; Giulia Grazzini; Francesca Grassi; Andrea Belli; Vittorio Miele; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2022-03-04       Impact factor: 2.965

9.  Development of CT-Based Imaging Signature for Preoperative Prediction of Invasive Behavior in Pancreatic Solid Pseudopapillary Neoplasm.

Authors:  Wen-Peng Huang; Si-Yun Liu; Yi-Jing Han; Li-Ming Li; Pan Liang; Jian-Bo Gao
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

Review 10.  Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging.

Authors:  Ginevra Danti; Federica Flammia; Benedetta Matteuzzi; Diletta Cozzi; Valentina Berti; Giulia Grazzini; Silvia Pradella; Laura Recchia; Luca Brunese; Vittorio Miele
Journal:  Radiol Med       Date:  2021-08-24       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.